Catalyst Pharmaceuticals, Inc. (CPRX)
USD 21.35
(-3.26%)
USD 21.35
(-3.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 398.2 Million | 214.2 Million | 140.83 Million | 119.07 Million | 102.3 Million | 500 Thousand |
| Cost of Revenue | 84.53 Million | 34.39 Million | 21.88 Million | 17.03 Million | 14.75 Million | 19.91 Million |
| Gross Profit | 313.67 Million | 179.81 Million | 118.94 Million | 102.03 Million | 87.54 Million | -19.41 Million |
| Operating Expenses | 259.42 Million | 77.97 Million | 66.56 Million | 60.73 Million | 55.72 Million | 35.79 Million |
| Selling, General and Administrative Expenses | 133.71 Million | 58.18 Million | 49.62 Million | 44.23 Million | 36.88 Million | 15.87 Million |
| Research and Development Expenses | 93.15 Million | 19.78 Million | 16.93 Million | 16.49 Million | 18.84 Million | 19.91 Million |
| Other Expenses | - | 2.88 Million | 282 Thousand | 586.89 Thousand | 1.58 Million | 1.29 Million |
| Cost and Expenses | 311.39 Million | 112.36 Million | 88.44 Million | 77.76 Million | 70.48 Million | 35.79 Million |
| Operating Income | 86.81 Million | 101.83 Million | 52.38 Million | 41.3 Million | 31.82 Million | -35.29 Million |
| Interest Expense | - | - | - | - | - | 1.29 Million |
| Income Tax Expense | 23.1 Million | 21.64 Million | 13.18 Million | -33.09 Million | 1.53 Million | 2.58 Million |
| Earnings before Tax | 94.51 Million | 104.71 Million | 52.66 Million | 41.89 Million | 33.4 Million | -34 Million |
| Net Income | 71.41 Million | 83.07 Million | 39.48 Million | 74.98 Million | 31.87 Million | -34 Million |
| Earnings Per Share Basic | 0.67 | 0.80 | 0.38 | 0.72 | 0.31 | -0.33 |
| Earnings Per Share Diluted | 0.63 | 0.75 | 0.37 | 0.71 | 0.30 | -0.33 |
| Weighted Average Shares Outstanding | 106.27 Million | 103.37 Million | 103.37 Million | 103.51 Million | 102.94 Million | 102.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.75 Million | 111.37 Million | 107.79 Million | 106.24 Million | 106.02 Million | 102.63 Million |
| Gross Margin | 0.79 | 0.84 | 0.84 | 0.86 | 0.86 | -38.84 |
| EBIT Margin | 0.22 | 0.48 | 0.37 | 0.35 | 0.31 | -70.59 |
| Profit Margin | 0.18 | 0.39 | 0.28 | 0.63 | 0.31 | -68.01 |
| EBITDA | 86.81 Million | 101.83 Million | 52.38 Million | 41.3 Million | 31.82 Million | -35.25 Million |
| Earnings Before Tax Margin | 0.22 | 0.48 | 0.37 | 0.35 | 0.31 | -70.59 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 122.71 Million | 98.5 Million | 110.56 Million | 398.2 Million | 102.68 Million | 99.58 Million |
| Cost of Revenue | 24.74 Million | 12.52 Million | 24.86 Million | 84.53 Million | 14.16 Million | 12.04 Million |
| Gross Profit | 97.96 Million | 85.98 Million | 85.7 Million | 313.67 Million | 88.52 Million | 87.53 Million |
| Operating Expenses | 43.71 Million | 58.86 Million | 44 Million | 226.86 Million | 125.7 Million | 40.83 Million |
| Selling, General and Administrative Expenses | 40.73 Million | 46.93 Million | 42.03 Million | - | 33.56 Million | 28.39 Million |
| Research and Development Expenses | 2.98 Million | 2.58 Million | 1.97 Million | - | 83.66 Million | 3.95 Million |
| Other Expenses | 9.34 Million | 1.96 Million | 5.01 Million | 7.69 Million | -833 Thousand | 1.81 Million |
| Cost and Expenses | 68.46 Million | 71.38 Million | 68.87 Million | 311.39 Million | 139.87 Million | 52.88 Million |
| Operating Income | 54.24 Million | 27.12 Million | 41.69 Million | 86.81 Million | -37.18 Million | 46.69 Million |
| Interest Expense | - | - | 1.7 Million | - | - | - |
| Income Tax Expense | 14.99 Million | 5.81 Million | 11.86 Million | 23.1 Million | -7.25 Million | 10.75 Million |
| Earnings before Tax | 55.78 Million | 29.08 Million | 46.7 Million | 94.51 Million | -38.02 Million | 48.51 Million |
| Net Income | 40.79 Million | 23.27 Million | 34.84 Million | 71.41 Million | -30.76 Million | 37.76 Million |
| Earnings Per Share Basic | 0.35 | 0.20 | 0.33 | - | -0.29 | 0.36 |
| Earnings Per Share Diluted | 0.33 | 0.19 | 0.31 | - | -0.29 | 0.33 |
| Weighted Average Shares Outstanding | 118.18 Million | 116.8 Million | 106.71 Million | 106.27 Million | 106.56 Million | 106.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.65 Million | 123.4 Million | 113.75 Million | 113.75 Million | 106.56 Million | 113.67 Million |
| Gross Margin | 0.80 | 0.87 | 0.78 | 0.79 | 0.86 | 0.88 |
| EBIT Margin | 0.52 | 0.37 | 0.46 | - | -0.28 | 0.56 |
| Profit Margin | 0.33 | 0.24 | 0.32 | 0.18 | -0.30 | 0.38 |
| EBITDA | 63.75 Million | 36.55 Million | 50.83 Million | - | -28.62 Million | 55.26 Million |
| Earnings Before Tax Margin | 0.44 | 0.28 | 0.38 | 0.22 | -0.36 | 0.47 |
ECM
CODI-PB
CNLPL
SYNX
BRNA
GRUMAB